TCT recap: SAFE PCI, CHAMPION PHOENIX & OPEN II

Kim Carollo | | Cardiovascular Business | Interventional Cardiology

The SAFE-PCI study found radial PCI led to fewer bleeding and vascular complications than femoral PCI in women.

The CHAMPION PHOENIX trial found that cangrelor lowered the rate of ischemic events during PCI, such as stent thrombosis, and did not significantly increase severe bleeding.

In OPEN II, investigators found the STENTYS Self-Apposing® Stent, a paclitaxel-eluting stent, to be safe and effective six months into a clinical trial.

Kim Carollo,

Contributor

Related Content

Boston Scientific finalizes Bolt Medical acquisition as FDA clears company’s IVL technology
Key takeaways from ACC.25: Advances in cardiovascular science
New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS
Dapagliflozin improves outcomes for elderly TAVR patients with heart failure
Bringing state-of-the-art healthcare to Florida heart patients
Cardiologists make case against routine interventions for asymptomatic severe AS

Around the web

Radiology Business
The impact of Trump tariffs on iodine contrast media costs

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.